bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares traded down 24.3% on Thursday . The stock traded as low as $0.28 and last traded at $0.22. 2,372 shares were traded during mid-day trading, a decline of 71% from the average session volume of 8,107 shares. The stock had previously closed at $0.29.
bioAffinity Technologies Stock Performance
The firm has a fifty day simple moving average of $0.43 and a 200 day simple moving average of $0.71.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Featured Stories
- Five stocks we like better than bioAffinity Technologies
- How to Calculate Return on Investment (ROI)
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How to Profit From Value Investing
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Should You Invest in Penny Stocks?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
